(PRESS RELEASE) BUCHAREST, Romania, 14-Apr-2020 — /EuropaWire/ — In light of the public health risks caused by the COVID-19 pandemic and the restrictive measures implemented in the Netherlands and elsewhere concerning the gatherings of people, Digi Communications N.V. (the Company) … Read the full press release
Posted in Business, Financial, Investment, Law, Media, Netherlands, News, Romania, Technology, Telecom
Tagged admission to trading, AFM, Android TV-based entertainment service, ASF, Bogdan Ciobotaru, Bucharest Stock Exchange, Business Continuity, buy back shares, buy-back program, BVB, Class A shares, Class B shares, conference call, coronavirus, COVID-19, Digi, DIGI 2019 Annual Report, DIGI 2019 Financial Statements, DIGI Annual Report 2019, Digi Communications, Digi Communications 2018 Preliminary financial results, Digi Communications Conference Call, Digi Communications N.V. AGM 2020, Digi Communications NV, DIGI GSM 2020, DIGI symbol, DIGI symbol 20 - 24 Jan 2020 transactions, directors stock option plans, Dutch Authority for the Financial Markets, Emil Jugaru, employees stock option plans, equity reserves, Euronext Dublin, financial transactions, General Shareholders Meeting, Hungary, Investor Relations, investors, IPO, Irish Stock Exchange, Marius Catalin Varzaru, market, mobile services, MVNO, Piotr Rymaszewski, regulated market, Regulation, Romania, Romanian Financial Supervisory Authority, Romanian National Securities Commission, romanian telecommunications provider, Securities, senior secured notes, Serghei Bulgac, shareholders, shares, shares buy-back, shares conversion, Spain, stock option plans, Telecom Market, TELECOMMUNICATION PROVIDER, telecommunications, telecommunications services, transactions, tv
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
